Stabilization of atherosclerotic plaques: New mechanisms and clinical targets

This publication has 67 references indexed in Scilit:

• Pleiotropic effects of statins: do they matter?
  Current Opinion in Lipidology, 2001
• Troglitazone Inhibits Atherosclerosis in Apolipoprotein E–Knockout Mice
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2001
• Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells.
  Journal of Clinical Investigation, 1998
• IFN-gamma potentiates atherosclerosis in ApoE knock-out mice.
  Journal of Clinical Investigation, 1997
• Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability.
  Journal of Clinical Investigation, 1996
• Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.
  Journal of Clinical Investigation, 1994
• Distinct patterns of expression of fibroblast growth factors and their receptors in human atheroma and nonatherosclerotic arteries. Association of acidic FGF with plaque microvessels and macrophages.
  Journal of Clinical Investigation, 1993
• Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content.
  Heart, 1993
• Production of tissue collagenase (matrix metalloproteinase 1) by human aortic smooth muscle cells in response to platelet-derived growth factor
  Atherosclerosis, 1991
• Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991